- Home
- VNDA vs EXFY Comparison
VNDA vs EXFY Comparison
Compare VNDA & EXFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- EXFY
- Stock Information
- Founded
- VNDA 2002
- EXFY 2008
- Country
- VNDA United States
- EXFY United States
- Employees
- VNDA N/A
- EXFY N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- EXFY Computer Software: Prepackaged Software
- Sector
- VNDA Health Care
- EXFY Technology
- Exchange
- VNDA Nasdaq
- EXFY Nasdaq
- Market Cap
- VNDA 237.9M
- EXFY 253.2M
- IPO Year
- VNDA 2006
- EXFY 2021
- Fundamental
- Price
- VNDA $4.22
- EXFY $3.06
- Analyst Decision
- VNDA Strong Buy
- EXFY Buy
- Analyst Count
- VNDA 2
- EXFY 4
- Target Price
- VNDA $16.50
- EXFY $5.00
- AVG Volume (30 Days)
- VNDA 500.0K
- EXFY 276.7K
- Earning Date
- VNDA 05-07-2025
- EXFY 05-08-2025
- Dividend Yield
- VNDA N/A
- EXFY N/A
- EPS Growth
- VNDA N/A
- EXFY N/A
- EPS
- VNDA N/A
- EXFY N/A
- Revenue
- VNDA $201,351,000.00
- EXFY $139,236,000.00
- Revenue This Year
- VNDA $14.36
- EXFY $9.56
- Revenue Next Year
- VNDA $44.53
- EXFY $6.86
- P/E Ratio
- VNDA N/A
- EXFY N/A
- Revenue Growth
- VNDA 13.37
- EXFY N/A
- 52 Week Low
- VNDA $3.85
- EXFY $1.24
- 52 Week High
- VNDA $6.75
- EXFY $4.13
- Technical
- Relative Strength Index (RSI)
- VNDA 41.17
- EXFY 55.91
- Support Level
- VNDA $4.20
- EXFY $2.78
- Resistance Level
- VNDA $4.64
- EXFY $3.00
- Average True Range (ATR)
- VNDA 0.17
- EXFY 0.13
- MACD
- VNDA 0.01
- EXFY 0.03
- Stochastic Oscillator
- VNDA 20.75
- EXFY 100.00
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
About EXFY Expensify Inc.
Expensify Inc is a cloud-based expense management software platform that helps various businesses simplify the way to manage money. It is used to scan and reimburse receipts from flights, hotels, coffee shops, office supplies and ride shares. People use Expensify's free features, which include corporate cards, expense tracking, next-day reimbursement, invoicing, bill pay and travel booking in one app.